SpinTech continues to extend the boundaries of MRI and recently earned FDA clearance for STAGE, a rapid, quantitative multi-contrast imaging software that integrates seamlessly into existing clinical workflows. STAGE includes the world’s first FDA cleared QSM output and can be used across a wide range of neurodegenerative disorders such as stroke, Multiple Sclerosis, Parkinson’s, traumatic brain injury, dementia, and tumor imaging. In addition, SpinTech offers automated CMB and Parkinson’s Reports that run on top of STAGE data to aid clinicians in detecting microbleeds and quantifying neuromelanin content, respectively.

Medical Devices

SpinTech MRI

Karen Holzberger

Mark Haacke

Jeff Eardley

James Backstrom

John Ciliberto

Paul Kokeny

Kiarash Ghassaban

Rana El Hachem

Miller Fawaz

Rachel Martis-Laze

SpinTech MRI's leadership team has a wealth of experience in the medical, programming, and business industries. Many on the team have worked together in various capacities over the years, including at Wayne State University, MR Innovations Inc., and the MRI Institute. The team's experience and education covers a wide range of specialties, from electrical engineering to neuroscience, giving them the unique ability to develop innovative new products and services for the MRI industry.

Leadership Team

CEO and Executive Team

Founding Team

Leadership Team

About

Team members

Other teams at SpinTech MRI

CEO and Executive Team

Founding Team